|
CN112142813A
|
|
Dehalogenation method and application of 9-halogenated steroid compound
|
|
CN112142821A
|
|
Synthesis method and application of 9-fluoro steroid compound
|
|
CN112142820A
|
|
Synthetic method of triamcinolone acetonide
|
|
CN112142573A
|
|
Method for synthesizing triclosan
|
|
CN111751455A
|
|
Method for detecting residual fluorobromomethane in bulk drug
|
|
CN111748010A
|
|
Methylprednisolone aceponate anhydrous crystal form and composition thereof
|
|
CN111751454A
|
|
Method for detecting content of ipratropium bromide intermediate I and related substances
|
|
CN111743858A
|
|
Pharmaceutical composition of bromfenac sodium
|
|
CN111374963A
|
|
Tiotropium solution for inhalation
|
|
CN111377822A
|
|
Preparation method of vilanterol
|
|
CN111380970A
|
|
Method for detecting content of methylprednisolone aceponate and related substances
|
|
CN111380969A
|
|
Detection method for content of fluticasone furoate and related substances
|
|
CN111380968A
|
|
Method for detecting content of odaterol and related substances
|
|
CN111377995A
|
|
Preparation method of prednisolone sodium benzoylsulfonate
|
|
CN111377991A
|
|
Preparation method of loteprednol etabonate
|
|
CN111157630A
|
|
Method for detecting benzyl oleate and benzyl oleate in progesterone injection
|
|
CN111077233A
|
|
Method for detecting content of diflunisal and related substances
|
|
CN111072743A
|
|
Synthetic method of loteprednol etabonate intermediate
|
|
CN110964075A
|
|
Preparation method of betamethasone phosphate and sodium salt thereof
|
|
CN110964077A
|
|
Oxidation synthesis method of steroid 11-keto compound
|
